NCT02133937View on ClinicalTrials.gov

A Study Investigating the Bioavailability of a High Concentration Liquid Formulation Versus a Reference Lyophilized Formulation of Gantenerumab in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Healthy Volunteer

Interventions

DRUG

gantenerumab

Single subcutaneous injection of a high concentration liquid formulation

DRUG

gantenerumab

Single subcutaneous injection of a lyophilized formulation

Trial Locations (1)

66219

Lenexa

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT02133937 - A Study Investigating the Bioavailability of a High Concentration Liquid Formulation Versus a Reference Lyophilized Formulation of Gantenerumab in Healthy Volunteers | Biotech Hunter | Biotech Hunter